Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Oseltamivir (Tamiflu) dosing strategies for use during influenza prophylaxis (VA01)

Trial Profile

Oseltamivir (Tamiflu) dosing strategies for use during influenza prophylaxis (VA01)

Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2018

At a glance

  • Drugs Oseltamivir (Primary) ; Probenecid
  • Indications Influenza virus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Mar 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov
    • 16 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top